Science
Mechanism of Action
As a synthetic recombinant analog of human VEGFA, Methionyl sh-Polypeptide-9 operates by engaging specific receptors on endothelial cells, initiating a cascade that stimulates angiogenesis—the formation of new microvessels. This process significantly augments microcirculation within the skin, enhancing the delivery of vital oxygen and nutrients to dermal layers. It actively nourishes fibroblast cells, which are critical for collagen synthesis, and promotes cellular proliferation and tissue regeneration. Furthermore, this peptide fortifies endothelial cells against oxidative stress by reducing levels of pro-inflammatory cytokine IL-1α, thereby improving skin resilience and barrier function while reactivating age-diminished regenerative processes and strengthening skin structure.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Scientific investigations indicate this peptide enhances skin health, repair, and resilience. It boosts the production of proteins essential for cell restructuring, contributing to smoother, firmer skin. Additionally, it increases vascular permeability, optimizing nutrient and oxygen exchange, which supports cellular rejuvenation and collagen maintenance. A study on VEGF expression in human dermal papilla cells confirmed its role in stimulating microvascular network development, vital for skin function and fibroblast nourishment.
- 02 A preclinical study demonstrated that sh-Polypeptide 9 exhibited higher activity than Minoxidil at a lower, unspecified dose in increasing VEGF, stimulating bFGF release, and promoting β-catenin production in human microvascular endothelial cells cocultured with follicle dermal papilla cells. It also provided protection against oxidative stress by reducing IL-1α levels.
Transparency
Dusting Analysis
There is no information within the provided data to suggest that Methionyl sh-Polypeptide-9 is commonly dusted or at what threshold, indicating it is likely utilized for its active benefits rather than as a filler.
The Formula
Formulation
Stability
While polypeptides generally exhibit pH-dependent stability, a specific optimal pH range for Methionyl sh-Polypeptide-9 is not detailed. The ingredient is frequently integrated using advanced double-layered capsulation technology to optimize skin penetration, enhance stability, and preserve purity.
Conflicts
- Individuals with psoriasis should meticulously avoid products containing sh-Polypeptide-9, as VEGFA activity is implicated in the progression of this dermatological condition.
Safety
Safety Profile
Methionyl sh-Polypeptide-9 is a synthetically produced fusion peptide derived from fermentation in E. coli. While the Cosmetic Ingredient Review (CIR) Expert Panel has assessed the safety of various other peptides, specific safety evaluations for Methionyl sh-Polypeptide-9 are not explicitly available in the provided data, nor is there a direct SCCS opinion or specific FDA status for cosmetic use. It is not currently listed on EWG's Skin Deep Restricted or Unacceptable Lists, generally suggesting a low-concern profile.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Methionyl sh-Polypeptide-9 is a highly valuable peptide, offering significant benefits in enhancing skin microcirculation, supporting regeneration, and providing robust anti-aging effects, though further specific clinical concentration data for dermal applications would strengthen its profile.
Related
Similar Ingredients
Finding similar ingredients…